Xiangtao Huang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction: SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression.
Journal: Cell death discovery
Published: April 08, 2025
Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis.
Journal: Transplantation and cellular therapy
Published: April 16, 2024
Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials.
Journal: Frontiers in immunology
Published: April 25, 2023
Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation-A systematic review and meta-analysis.
Journal: Bone marrow transplantation
Published: September 07, 2022
Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis.
Journal: Bone marrow transplantation
Published: July 27, 2022
Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation.
Journal: Annals of transplantation
Published: October 12, 2021
Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials.
Journal: Stem cell research & therapy
Published: August 20, 2021
SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression.
Journal: Cell death discovery
Published: April 10, 2021
Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies.
Journal: Stem cell research & therapy
Published: January 14, 2021
Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis.
Journal: Scientific reports
Published: March 23, 2020
Last Updated: 09/26/2026